There are currently 1274 clinical trials in Cleveland, Ohio looking for participants to engage in research studies. Trials are conducted at various facilities, including Cleveland Clinic, Cleveland Clinic Foundation, Case Western Reserve University and University Hospitals Cleveland Medical Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Recruiting
The researchers are doing this study to find out whether the combination of ruxolitinib and ulixertinib is a safe and effective treatment for people with myelofibrosis. The researchers will test different doses of ulixertinib to find the highest dose that causes few or mild side effects in participants when given in combination with ruxolitinib.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/08/2025
Locations: Cleveland Clinic, Cleveland, Ohio
Conditions: Myelofibrosis
Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
Recruiting
Durable left ventricular assist devices (dLVAD) have been increasingly utilized since the mid to late 1990s, with an uptick of utility starting in 2010 following expanded indications for therapy to not only include a bridge to transplantation strategy, but also for those individuals who suffer from advanced heart failure (HF) and do not qualify for cardiac transplantation. Despite the decreasing size of the newest generation devices leading to a lessened occurrence of adverse events, bleeding an... Read More
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
01/08/2025
Locations: UH Cleveland Medical Center, Cleveland, Ohio
Conditions: LVAD, Frailty, GI Bleed, Right Heart Failure, Infections, Hypertension, Arrhythmias, Stroke
Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis
Recruiting
Inflammatory responses in response to alcohol have been identified as contributing to the development of alcoholic hepatitis. The inflammatory response including that to LippoPolySaccharide is known to lead to progression of alcoholic liver disease. In addition to the inflammatory response mitochondrial perturbations exist and redox homeostasis is altered in patients with alcoholic hepatitis. Though this is known there have been very few studies targeting mitochondrial function in Peripheral Blo... Read More
Gender:
ALL
Ages:
Between 21 years and 65 years
Trial Updated:
01/08/2025
Locations: Cleveland Clinic Foundation, Cleveland, Ohio
Conditions: Alcoholic Hepatitis
Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19
Recruiting
Patients with COVID-19 and comorbidities including alcohol associated liver disease (ALD) are at risk for severe illness and abrupt or sudden clinical deterioration with ventilatory failure. â-hydroxy â-methyl butyrate (HMB), a non-nitrogenous leucine metabolite with anabolic properties, increases muscle mass and contractile function and enhances immune function. We aim to study the natural course of COVID-19 in patients with ALD and test whether HMB can affect ventilatory deterioration and impr... Read More
Gender:
ALL
Ages:
21 years and above
Trial Updated:
01/08/2025
Locations: Cleveland Clinic Foundation, Cleveland, Ohio
Conditions: Alcoholic Liver Disease, COVID 19 Pneumonia
Milk Thistle Clinical Trial in Pediatric NAFLD
Recruiting
Pediatric Fatty Liver disease is a growing problem in the United States and is expected to be the leading cause of Liver Transplantation in Adults in 20 years. Following lifestyle changes such as diet restrictions and exercise may be difficult to consistently maintain. The purpose of this study is to investigate alternative medical therapy with an herbal supplement called Milk Thistle (MT) which may improve fatty liver disease and would be easier to follow than diet and exercise.
Gender:
ALL
Ages:
Between 9 years and 22 years
Trial Updated:
01/07/2025
Locations: University Hospitals Cleveland Medical Center, Cleveland, Ohio
Conditions: Non-Alcoholic Fatty Liver Disease (NAFLD)
Comparing Reduction With ESD- Versus APC-TORe
Recruiting
The goal of this clinical trial is to compare two variations of the same procedure used to assist with weight loss in patients who have a history of Roux-en-Y gastric bypass who have experienced weight regain. The procedure being studied is called the Transoral Outlet Reduction (TORe), and the trial will compare two different ways to complete the TORe procedure. The main question\[s\] it aims to answer are: * Which variation of the TORe procedure results in more weight loss? * Which variation o... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/07/2025
Locations: Cleveland Clinic Foundation, Cleveland, Ohio
Conditions: Obesity, Roux-en-y Anastomosis Site, Weight Gain
OPEN Versus InTact Capsule Proton Pump Inhibitors for the Treatment of Marginal Ulcers
Recruiting
The goal of this clinical trial is to identify the most effective way to take acid-blocking medications to treat stomach ulcers in patients who have undergone gastric bypass surgery. The main questions it aims to answer are: * is taking an acid-blocking medication by opening the capsule and only taking the contents of the capsule (open-capsule) more or less effective than taking the capsule as a whole (intact-capsule) for treating ulcers in patients who have a history of gastric bypass surgery?... Read More
Gender:
ALL
Ages:
All
Trial Updated:
01/07/2025
Locations: Cleveland Clinic Foundation, Cleveland, Ohio
Conditions: Marginal Ulcer
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
Recruiting
Evaluating outcomes after bilateral implantation of ICLs or bilateral LASIK as treatment options for the correction or reduction of myopia with or without astigmatism.
Gender:
ALL
Ages:
Between 21 years and 45 years
Trial Updated:
01/07/2025
Locations: Cleveland Eye Clinic, Cleveland, Ohio
Conditions: Myopia
Sarcopenia Magnetic Resonance Imaging Evaluation (SUSIE)
Recruiting
The goal of the proposed research is to investigate Magnetic Resonance (MR) Fingerprinting and P-MRS (Phosphorus-31 MR Spectroscopy) imaging for characterization of skeletal muscle in heart failure patients with sarcopenia. Heart failure patients with and without sarcopenia will be scanned using MR Fingerprinting and an existing Post-exercise phosphocreatine (PCr) recovery MR imaging protocol to obtain characteristic profiles of quantitative T1, T2, and PCr recovery rate.
Gender:
ALL
Ages:
40 years and above
Trial Updated:
01/06/2025
Locations: Cleveland Clinic, Cleveland, Ohio
Conditions: Sarcopenia
TVMR with the Innovalve System Trial - Early Feasibility Study
Recruiting
Study to evaluate the safety and performance of the Innovalve mitral valve replacement system
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/06/2025
Locations: Cleveland Clinic, Cleveland, Ohio
Conditions: Mitral Valve Regurgitation (Degenerative or Functional)
Patient Recall of Cancer Screening and Diagnosis
Recruiting
The purpose of this research is to try to better understand how much information relating to cancer screening and diagnoses that people can recall on their own and to better understand how to help people get better information. In this study, investigators will see if giving time or other resources help individuals remember more and more accurate details about their cancer screening and care.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/06/2025
Locations: Case Comprehensive Cancer Center, Cleveland, Ohio
PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19
Recruiting
This study is an adaptive, randomized, double blind, platform trial evaluating promising investigational products (IP) for safety and efficacy as early outpatient treatment and post-exposure prophylaxis for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/06/2025
Locations: University Hospitals Cleveland Medical Center, Cleveland, Ohio
Conditions: SARS-CoV-2